These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 2812318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study.
    Meguro K, Yamaguchi S, Itoh M, Fujiwara T, Yamadori A.
    Neurology; 1997 Oct; 49(4):941-5. PubMed ID: 9339671
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.
    Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, Pietrini P, Salerno JA, Heston LL, Rapoport SI, Horwitz B.
    J Cereb Blood Flow Metab; 1993 May; 13(3):438-47. PubMed ID: 8478402
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C, Chiaravalloti A, Sancesario G, Stefani A, Sancesario GM, Mercuri NB, Schillaci O, Pierantozzi M.
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
    Friedland RP, Budinger TF, Koss E, Ober BA.
    Neurosci Lett; 1985 Feb 04; 53(3):235-40. PubMed ID: 3872424
    [Abstract] [Full Text] [Related]

  • 11. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD.
    J Cereb Blood Flow Metab; 1991 May 04; 11(3):485-91. PubMed ID: 2016357
    [Abstract] [Full Text] [Related]

  • 12. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 04; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 13. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q, Jiang K, Liu Y, Zhang M, Xiao S, Zuo C, Huang H.
    Zhonghua Yi Xue Za Zhi; 2002 Dec 10; 82(23):1613-6. PubMed ID: 12667368
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
    Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI.
    Brain Res; 1987 Mar 31; 407(2):294-306. PubMed ID: 3494486
    [Abstract] [Full Text] [Related]

  • 18. Cortical abnormalities in Alzheimer's disease.
    Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G.
    Ann Neurol; 1984 Dec 31; 16(6):649-54. PubMed ID: 6335378
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD, Szelies B, Kessler J, Herholz K.
    Ann N Y Acad Sci; 1991 Dec 31; 640():65-71. PubMed ID: 1776760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.